Nuclear drugs to target and eliminate colorectal cancer
Researchers at Memorial Sloan Kettering Cancer Center and the Massachusetts Institute of Technology have developed a new three-step system that uses nuclear drugs to target and eliminate colorectal cancer. The researchers obtain..
Fiber intake reduces mortality in patients with non-metastatic colorectal cancer
Mingyang Song of Harvard Medical School and Massachusetts General Hospital reported that after diagnosis of non-metastatic colorectal cancer, ingesting more fiber will reduce the specific mortality and overall mortality of colorec..
Adding SIRT to chemotherapy can improve survival in colorectal cancer
Colorectal cancerThe researchers found that adding SIRT to chemotherapy can improve the survival rate of colorectal cancerNew research shows that for patients with colorectal cancer who have only liver metastases or mainly liver..
American Mayo Clinic experts talk about the treatment of rectal cancer
Rectal cancer is cancer that occurs in the last few inches of the colon. This area is called the rectum. The main treatment for rectal cancer is surgery. Depending on the progress of the cancer, radiation therapy and chemother..
Treatment strategy for oligometastatic advanced colorectal cancer
The concept of oligometastasis was proposed by Hellman in 1995. He pointed out that the lesion refers to some intermediate states between the localized growth of the tumor and systemic metastasis. Oligometastasis is organ-spe..
Anti-PD-L1 immunotherapy combined with MEK inhibitor for metastatic colorectal cancer
At the 18th World Congress of Gastrointestinal Cancer, a phase I clinical study showed that anti-PD-L1 immunotherapy combined with MEK inhibitors can effectively treat microsatellite stable metastatic colorectal cancer.The lead in..
Application and evaluation of KRAS gene mutation method for colorectal cancer
Targeting drugs such as cetuximab and panitumumab have been widely used in clinic as effective therapeutic drugs for colorectal cancer. Clinical data show that patients with KRAS mutations have no significant effect on this monoc..
Lonsurf for the treatment of refractory metastatic colorectal cancer
Japanese pharmaceutical company Otsuka (Otsuka) recently received good news in the US regulatory aspects, FDA approved anti-cancer compound new drug Lo 3 months in advancensurf (trifluridine / tipiracil, FTD / TPI) is used t..